Psoriasis Treatment Market Size, Share, Opportunities, Development and Global Trend Analysis till 2026
Aug 12, 2019
Psoriasis Treatment Market Size, Share and Global Trend By Treatment (Bipolar Psoriasis Treatment, Topical Treatments, Oral Or Injected Medications, Phototherapy, Others), By Route of Administration (Oral, Topical, Parenteral, Rectal, Sublingual), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales), And Geography Forecast Till 2026
Pune, India - August 12, 2019 /MarketersMedia/ —
The rising prevalence of psoriasis cases is fueling the demand among patients and enabling the growth of the global psoriasis treatment market says Fortune Business insights in a report titled “Psoriasis Treatment Market Size, Share and Global Trend By Treatment (Bipolar Psoriasis Treatment, Topical Treatments, Oral Or Injected Medications, Phototherapy, Others), By Route of Administration (Oral, Topical, Parenteral, Rectal, Sublingual), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales), And Geography Forecast Till 2026”. Increasing research and development on psoriasis treatment is propelling the growth of the psoriasis treatment market
Browse Complete Report:
https://www.fortunebusinessinsights.com/industry-reports/psoriasis-treatment-market-100600
Top Leaders Overview:
Some of the leading companies in the global Psoriasis Treatment Market:
• UCB
• Novartis
• Boehringer Ingelheim International GmbH
• Amgen
• LEO Pharma
• Pfizer
• Eli Lilly and Company
• Johnson & Johnson
• Merck
• AstraZeneca
• Celgene Corporation
Increasing R&D for Psoriasis Treatment to Aid Market Growth
Psoriasis is a chronic autoimmune disease, categorized by conditions which involve itchy dry patches and skin cells building up and forming scales. There is no such cure for the disease, so most of the emphasis of the treatment rests on the easing of symptoms. The course of treatment is determined by a number of factors such as the severity of psoriasis, the treatments already used, the existence of other medical conditions, the amount of treatment the patient is willing to do and the insurance plan of the patient. Factors which cause psoriasis include environmental triggers such as stress, injury to skin, infection, certain medications; the genetics of the patients; the immune system; the existence of comorbidities such as diabetes, Crohn’s Disease, high cholesterol, high blood pressure, depression, and cardiovascular diseases, etc. The rising cases of the aforementioned diseases are fueling the demand for psoriasis treatment and fostering the growth for psoriasis treatment market.
Psoriasis treatment market is witnessing a rising demand in response tothe increasing incidence of the disease across many countries. This is also due to the fact, that psoriasis is associated with various other diseases such as obesity, diabetes, cardiovascular diseases thus making it an upward trend for the global market. According to tThe World Health Organization (WHO), the prevalence of psoriasis in the U.S. has increased from 1.62% in 2004 to 3.10% in 2010. In Norway, a 30-year period study observed that Psoriasis in adults increased from 4.8% in 1979 to 11.4% in 2008. The rising prevalence of psoriasis cases, the new drug approvals from Food and Drug Administration (FDA), and increasing research and development along with new scientific discoveries are some of the factors that are expected to propel the growth of the global psoriasis market.
FDA Approves TREMFYA™; Novel Drug Approvals to Aid Market Expansion
Janssen Biotech, Inc., a biotechnology company unveiled TREMFYA™ for the treatment of severe plaque psoriasis and systematic therapy in adults, after getting approval from the Food and Drug Administration. The company claimed that TREMFYA™-treated patients can achieve at least 90 percent clearer skin and improvements involving the scalp, stinging, burning and skin tightness at week 16. The treatment being the first and only biologic therapy is expected to witness high demand among patients to avail the therapy which will, in turn, boost the Psoriasis treatment market. Key players are launching new drugs and therapies for the treatment of psoriasis for instance, in 2018 Sun Pharmaceutical Industries Ltd., received European Commission approval for plaque psoriasis treatment tildrakizumab (Ilumetri). New initiatives by companies for treating severe and moderate psoriasis are predicted to drive the global psoriasis market.
Get Sample PDF:
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/psoriasis-treatment-market-100600
North America to Dominate the Global Market
Geographically, the global psoriasis treatment market is segmented into North America, Europe, Asia-Pacific, Latin America. North America is leading the global psoriasis treatment market and is expected to grow at a substantial rate during the forecast period. Rising prevalence of psoriasis, increasing health infrastructure along with the presence of leading companies is expected to boost the psoriasis treatment market. Asia- Pacific is predicted to grow at a moderately low rate, owing to the fewer cases of psoriasis in countries such as India, China and others
Some of the major companies that are present in the global psoriasis treatment market are UCB S.A, Novartis AG, Boehringer Ingelheim International GmbH, Amgen Inc., LEO Pharma A/S, Pfizer Inc., Eli Lilly and Company, Johnson & Johnson Services, Inc., Merck & Co., AstraZeneca, and Celgene Corporation. and others.
Speak to Analyst:
https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/psoriasis-treatment-market-100600
TABLE OF CONTENT:
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. Prevalence of Psoriasis and Psoriatic Arthritis for Key Countries/Region
4.2. Recent Industry Developments Such as Partnerships, Mergers & Acquisitions, New Product Launches Etc.
4.3. Pipeline Analysis for Key Companies
4.4. Regulatory Framework by Key Countries
4.5. Global Reimbursement Scenario
5. Global Psoriasis Treatment Market Analysis, Insights and Forecast, 2015-2026
TOC Continued…!
About Us:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
View More Reports:
Contact Info:
Name: Ashwin Arora
Email: Send Email
Organization: Fortune Business Insights Pvt Ltd
Address: Fortune Business Insights Pvt. Ltd., 308, Supreme Headquarters,, Survey No. 36, Baner,, Pune-Bangalore Highway,, Pune - 411045, Maharashtra, India.
Phone: +144242530390
Website: https://www.fortunebusinessinsights.com/
Source: MarketersMedia
Release ID: 88906988
More News
How to earn Qantas status credits without getting on a plane
Qantas frequent flyer program members can now earn status credits without flying. Here’s what you have to do.
France faces a ‘doom loop’ as it spirals downwards
A perfect storm of unhappy citizens and wary investors has France facing an economic crisis.
Japanese top chef sacked after drinking on the job wins $11k payout
A chef worked at a high-end Sydney restaurant. The fair work umpire ruled his dismissal was harsh, unjust and unreasonable.
ASX finishes higher as banks rise, NextDC tanks; CSL names new CEO
The Australian sharemarket whipsawed on Wednesday as banks and tech stocks advanced and data centre company NextDC plunged.
Manhattan Gold reveals high-grade 2.25km Canadian gold footprint
Manhattan Gold’s maiden drilling revealed district-scale potential at its Hook Lake project in Canada, with high-grade gold and a new polymetallic discovery uncovered.
Inside Ben Roberts-Smith’s media campaign for support
The disgraced war hero’s public relations offensive includes a two-and-a-half hour media interview, the launch of a clothing brand and an Instagram page.
Mining giant fires top executive after sexual harassment probe
The Andrew Forrest-backed miner has sacked a manager at the centre of a months-long sexual harassment and bullying investigation.
Locksley gears up for major NSW copper-gold drilling push
Locksley Resources established a field base at its vast 1000-square-kilometre Greater Tottenham copper-gold project in NSW, advancing plans for a 15,500m drilling blitz.
Red Metal scales up leach tests at QLD rare earths monster
Red Metal is putting its monster Sybella rare earths resource to the processing test, kicking off six-metre column leach trials to prove whether it can develop a cheap, heap leaching QLD operation.
Orbit strikes more massive sulphides in NSW’s Lachlan Fold
Orbit Resources has hit 11.8m of massive sulphides at its Lewis Ponds project in NSW, including 3.55m estimated at 50 of the precious sulphides, with assays pending.
Sarytogan reveals $190M Kazakh graphite plan spanning 50 years
Sarytogan Graphite’s definitive feasibility study has valued its 50,000tpa Kazakh graphite project at A$190M, with just A$115M in upfront capital earmarked for a 50-year operation.
Sarytogan study puts 50-year plan around Kazakh graphite giant
Sarytogan Graphite’s definitive feasibility study has valued its 50,000tpa Kazakh graphite project at A$190M, with just A$115M in upfront capital earmarked for a 50-year operation.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.